apresoline 50 tablet
novartis south africa (pty) ltd - tablet - each tablet contains hydralazine 50 mg
apresoline 25 mg tablets coated tablet
amdipharm limited amdipharm limited, temple chambers, 3 burlington - hydralazine hydrochloride - coated tablet - 25mg - agents acting on arteriolar smooth muscle:
apresoline 50
pharmaco districution (pty) ltd - hydralazine hydrochloride - tablet - 50 mg/tablet
hydralazine hydrochloride injection solution
fresenius kabi canada ltd - hydralazine hydrochloride - solution - 20mg - hydralazine hydrochloride 20mg - direct vasodilators
hydralazine hydrochloride injection, usp solution
auro pharma inc - hydralazine hydrochloride - solution - 20mg - hydralazine hydrochloride 20mg - direct vasodilators
hydralazine 25mg tablets
kent pharma (uk) ltd - hydralazine hydrochloride - oral tablet - 25mg
hydralazine 25mg tablets
alliance healthcare (distribution) ltd - hydralazine hydrochloride - oral tablet - 25mg
hydralazine 25mg tablets
advanz pharma - hydralazine hydrochloride - oral tablet - 25mg
ser-ap-es- reserpine, hydralazine hydrochloride and hydrochlorothiazide tablet, coated
novartis pharmaceuticals corporation - hydralazine hydrochloride (unii: fd171b778y) (hydralazine - unii:26nak24ls8), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), reserpine (unii: 8b1qwr724a) (reserpine - unii:8b1qwr724a) - tablet, coated - 25 mg - hypertension (see boxed warning). hypersensitivity to reserpine; mental depression or history of mental depression (especially with suicidal tendencies); active peptic ulcer, ulcerative colitis; patients receiving electroconvulsive therapy. hypersensitivity to hydralazine; coronary artery disease; mitral valvular rheumatic heart disease. anuria; hypersensitivity to this or other sulfonamide-derived drugs.
pantominovit wsp
pantex - vit a 10,000 iu,d3 1000iu,vit e 10mg,vit b1 2mg,vit b 4mg,c 25mg,lysine 50mg,methionine 50mg,inositl 8mg,folic acid 500mcg etc